PlainRecalls
FDA Drug Moderate Class II Ongoing

Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05

Reported: April 26, 2023 Initiated: March 17, 2023 #D-0539-2023

Product Description

Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05

Reason for Recall

Out of specification (OOS) for Spectroscopic Identification test by IR.

Details

Recalling Firm
Ascend Laboratories, LLC
Units Affected
135 bottles
Distribution
Nationwide in the USA
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05. Recalled by Ascend Laboratories, LLC. Units affected: 135 bottles.
Why was this product recalled?
Out of specification (OOS) for Spectroscopic Identification test by IR.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 26, 2023. Severity: Moderate. Recall number: D-0539-2023.